Evidence map›Paper›PMID 39769023›Full record

ArticleInternational journal of molecular sciences2024

Directed Mutagenesis for Arginine Substitution of a

Dania Martínez-Alarcón, José Luis Castro-Guillén, Elaine Fitches, John A Gatehouse, Stefan Przyborski, Ulisses Moreno-Celis, Alejandro Blanco-Labra, Teresa García-Gasca

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Pharmaceuticals (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dania Martínez-AlarcónCentro de Investigación y de Estudios Avanzados Unidad Irapuato, Departamento de Biotecnología y Bioquímica, Irapuato 36821, Guanajuato, Mexico.ORCID 0000-0001-8204-7408
José Luis Castro-GuillénTecnológico Nacional de México/Instituto Tecnológico Superior de Irapuato (ITESI), Km. 12.5, Carretera Irapuato-Silao, El Copal, Irapuato 36821, Guanajuato, Mexico.ORCID 0000-0002-2080-2866
Elaine FitchesDepartment of Biosciences, Durham University, Durham DH1 3LE, UK.ORCID 0000-0003-0565-8672
John A GatehouseDepartment of Biosciences, Durham University, Durham DH1 3LE, UK.
Stefan PrzyborskiDepartment of Biosciences, Durham University, Durham DH1 3LE, UK.ORCID 0000-0001-7613-525X
Ulisses Moreno-CelisFacultad de Ciencias Naturales, Universidad Autónoma de Querétaro, Querétaro 76230, Querétaro, Mexico.ORCID 0000-0003-3751-6601
Alejandro Blanco-LabraCentro de Investigación y de Estudios Avanzados Unidad Irapuato, Departamento de Biotecnología y Bioquímica, Irapuato 36821, Guanajuato, Mexico.
Teresa García-GascaFacultad de Ciencias Naturales, Universidad Autónoma de Querétaro, Querétaro 76230, Querétaro, Mexico.ORCID 0000-0002-8793-9963

Funding

Consejo Nacional de Humanidades, Ciencias y Tecnologías Ciencia de Frontera (171873).
6 · The paper itself

Abstract

Recently, we reported that a recombinant Tepary bean (

Indexed as

ArgininePhaseolusPlant LectinsAmino Acid SubstitutionErbB ReceptorsHT29 CellsHumansMolecular Docking SimulationMutagenesis, Site-DirectedPolysaccharidesProtein BindingRecombinant ProteinsArginineErbB ReceptorsPlant LectinsPolysaccharidesRecombinant Proteinsbranched N-glycanscancerrecombinant lectinstepary bean

Identifiers

PMID39769023
PMCPMC11676905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.